(Date:5/12/2008)...roject proceeds despite non-compliance with Califo...y Act (CEQA)., LOS ANGELES, May 12 /PRNewswire-US...(PHCMC) today went ahead with the planned expansio...r Court Judge Thomas I. McKnew,Jr. has upheld cha...lawed.,The groundbreaking ceremony held today appe...
(Date:5/12/2008)... First approved dental anesthetic reversa...r Pharmaceuticals, Inc., a,dental specialty pharma...States Food and Drug Administration (FDA) has gran...ine mesylate). OraVerse is the first,pharmaceutica...anesthesia,and the associated functional deficits ...
(Date:5/12/2008)...GAITHERSBURG, Md., May 12 /PRNewswire-FirstCall/ -...at it will host a conference call and live,webcast...ercell AG (VSE:,ICLL) and Iomai have entered into ... will acquire Iomai for USD 6.60 per share represe...y USD 189 million (EUR 122 million)., The confere...
(Date:5/12/2008)...PHOENIX, May 12 /PRNewswire-FirstCall/ -- NutraCea...bilized rice bran (SRB), nutrient research and,tec... first quarter ended,March 31, 2008. Consolidated ...st quarter of 2008, compared to consolidated net r...007. The $3.1 million increase was,primarily due t...
Breaking Medicine News(10 mins):Health News:Providence Holy Cross Medical Center Ignores Community, Environmental Concerns With Planned Expansion of Mission Hills Facility 2Health News:Novalar Receives FDA Approval for OraVerse(TM) 2Health News:Novalar Receives FDA Approval for OraVerse(TM) 3Health News:Iomai to Host Conference Call and Webcast Tomorrow, Tuesday, May 13, at 8:30 a.m. EDT 2Health News:Iomai to Host Conference Call and Webcast Tomorrow, Tuesday, May 13, at 8:30 a.m. EDT 3Health News:NutraCea Announces First Quarter 2008 Financial Results 2Health News:NutraCea Announces First Quarter 2008 Financial Results 3Health News:NutraCea Announces First Quarter 2008 Financial Results 4Health News:NutraCea Announces First Quarter 2008 Financial Results 5Health News:NutraCea Announces First Quarter 2008 Financial Results 6(Date:5/8/2008)...Network Completes 13 Phase-I Clinical Trials; Re...opment, EL SEGUNDO, Calif., May 8 /-...linical trial research service business specializi...evelopment for FDA approval,reports it completed ... 34,active trials in late stage drug development-a...
(Date:5/8/2008)...improvement in ADHD symptoms in adults, WASHINGTO... SHP,Nasdaq: SHPGY), the global specialty biophar... a phase III pivotal study in which VYVANSE,demons...it Hyperactivity,Disorder (ADHD) symptoms in adult...ults with ADHD often find it challenging to focus ...
(Date:5/8/2008)...to Produce Therapeutic Proteins at Tumor,Site, ...ire/ -- Using gene,therapy, plastic surgeons have ...aps placed on cancerous tumors on rats with a 79 p...tudy in the May issue of Plastic and,Reconstructiv...American,Society of Plastic Surgeons (ASPS). This ...
(Date:5/8/2008)... Center Investigators to Assess BSI-201 ..., BRISBANE, Calif., May 8 /- BiPar S...se 2 clinical trial programs for its lead,product,...or clinical trial,of BSI-201 that BiPar has launch...als in breast and brain cancer., The company is e...
Breaking Medicine Technology:DaVita Clinical Research Completes Record Number of Renal Trials in 2007 2Results of the Phase III Pivotal Study of VYVANSE(TM) (Lisdexamfetamine Dimesylate) for the Treatment of ADHD in Adults Presented at National Scientific Meeting of Psychiatrists 2Results of the Phase III Pivotal Study of VYVANSE(TM) (Lisdexamfetamine Dimesylate) for the Treatment of ADHD in Adults Presented at National Scientific Meeting of Psychiatrists 3Results of the Phase III Pivotal Study of VYVANSE(TM) (Lisdexamfetamine Dimesylate) for the Treatment of ADHD in Adults Presented at National Scientific Meeting of Psychiatrists 4Results of the Phase III Pivotal Study of VYVANSE(TM) (Lisdexamfetamine Dimesylate) for the Treatment of ADHD in Adults Presented at National Scientific Meeting of Psychiatrists 5Skin Flaps Deliver Cancer-fighting Therapy, ASPS Study Reveals 2Skin Flaps Deliver Cancer-fighting Therapy, ASPS Study Reveals 3BiPar Sciences Expands Phase 2 Clinical Trials of BSI-201, a Novel DNA Repair Inhibitor, in Ovarian Cancer 2Britney and K Fed doing it all wrong MU family researcher says 6222 1Britney and K Fed doing it all wrong MU family researcher says 6222 2Childrens Hospital Los Angeles Turns Off the Tap With Green Earth Waterless Carwash 6220 1Childrens Hospital Los Angeles Turns Off the Tap With Green Earth Waterless Carwash 6220 2Novartis Vaccines Partners With RediClinic for Holiday Vaccination Clinic Making Influenza Vaccination Convenient for Shoppers 6216 1Novartis Vaccines Partners With RediClinic for Holiday Vaccination Clinic Making Influenza Vaccination Convenient for Shoppers 6216 2Novartis Vaccines Partners With RediClinic for Holiday Vaccination Clinic Making Influenza Vaccination Convenient for Shoppers 6216 3Novartis Vaccines Partners With RediClinic for Holiday Vaccination Clinic Making Influenza Vaccination Convenient for Shoppers 6216 4Novartis Vaccines Partners With RediClinic for Holiday Vaccination Clinic Making Influenza Vaccination Convenient for Shoppers 6216 5Novartis Vaccines Partners With RediClinic for Holiday Vaccination Clinic Making Influenza Vaccination Convenient for Shoppers 6216 6Hormonal Changes and Depression 3A What is the Connection 3F 6212 1Hormonal Changes and Depression 3A What is the Connection 3F 6212 2Hormonal Changes and Depression 3A What is the Connection 3F 6212 3Hormonal Changes and Depression 3A What is the Connection 3F 6212 4...ESS WIRE)--Apr 12, 2007 - INNOVIVE Pharmaceuticals... preclinical,studies of INNO-406, a potent oral du...sistant or treatment-intolerant chronic,myelogenou...ciation,for Cancer Research Annual Meeting. The me...eles Convention Center in Los Angeles,California....
...inical Data Presented on Valopicitabine Combined,w...NA, Spain, April 12, 2007 /PRNewswire-FirstCall/ -...ults from two phase,IIb studies of the novel combi...erferon alfa-2a (Pegasys(R)) in both treatment-nai...th the genotype-1,strain of the hepatitis C virus ...
Other Medicine Technology:Innovive Pharmaceuticals Announces Additional Data Presentations at,American Association for Cancer Research Annual Meeting 2Idenix Reports Results from Two Phase IIb Studies of the,Combination of Valopicitabine and Pegylated Interferon in Hepatitis,C Genotype-1 Patients at the 42nd Annual Meeting of the European,Association for the Study of the Liver 2Idenix Reports Results from Two Phase IIb Studies of the,Combination of Valopicitabine and Pegylated Interferon in Hepatitis,C Genotype-1 Patients at the 42nd Annual Meeting of the European,Association for the Study of the Liver 3Idenix Reports Results from Two Phase IIb Studies of the,Combination of Valopicitabine and Pegylated Interferon in Hepatitis,C Genotype-1 Patients at the 42nd Annual Meeting of the European,Association for the Study of the Liver 4Idenix Reports Results from Two Phase IIb Studies of the,Combination of Valopicitabine and Pegylated Interferon in Hepatitis,C Genotype-1 Patients at the 42nd Annual Meeting of the European,Association for the Study of the Liver 5Idenix Reports Results from Two Phase IIb Studies of the,Combination of Valopicitabine and Pegylated Interferon in Hepatitis,C Genotype-1 Patients at the 42nd Annual Meeting of the European,Association for the Study of the Liver 6Idenix Reports Results from Two Phase IIb Studies of the,Combination of Valopicitabine and Pegylated Interferon in Hepatitis,C Genotype-1 Patients at the 42nd Annual Meeting of the European,Association for the Study of the Liver 7pHix Strips easily fix the catheter on the nose and are made of microporous tape allowing the skin to breathe.
...e multi-use catheters are designed using establish...with the following benefits:, ,Working with pH ca...ere the multi-use catheter is used the Hellige Ele...E: ,Medtronic pH measurement systems have been des...
...e single-use pH catheters are efficient, economica...llow greater patient comfort during the test perio... been designed to use temperature correction facto...tion. The temperature correction factors for Bravo...
The WaveMax is one of the most flexible stainless steel stents due to its unique wave design and has the lowest effective profile, accommodating a 6F sheath up to 7 mm.
Medicine Products: